n Cardiovascular Journal of South Africa - ARBITER-2 : evidence that targeting HDL cholesterol slows atherosclerosis : drug trends in cardiology

Volume 16, Issue 1
  • ISSN : 1680-0745



Extracted from text ... Addition of a prolonged-release nicotinic acid (not yet available in SA) to statin therapy arrested progression of atherosclerosis among coronary heart disease (CHD) patients with low levels of highdensity lipoprotein (HDL) cholesterol in the ARBITER-2 study.1 Prof. Derick Raal, Head of the Division of Endocrinology and Metabolism, Department of Medicine, Johannes burg Hospital, noted at a special media briefing in Johannesburg that this means that nicotinic acid is currently the most potent drug available to physicians to raise HDL cholesterol. The ARBITER-2 (ARterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol) study included 167 patients with known ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error